Pembrolizumab and Chemotherapy in Newly-Diagnosed, Early Unfavorable or Advanced Stage Classic Hodgkin Lymphoma: The Phase 2 Keynote-C11 Study
64th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Louisiana, United States Of America, 10 - 13 December 2022, pp.1759-1760, (Summary Text)
- Publication Type: Conference Paper / Summary Text
- Doi Number: 10.1182/blood-2022-163787
- City: Louisiana
- Country: United States Of America
- Page Numbers: pp.1759-1760
- Ankara University Affiliated: Yes